Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.38 |
| ▸ | PPARG | P37231 | 7/20 | 0.38 |
| ▸ | PPARD | Q03181 | 7/20 | 0.38 |
| ▸ | PPARA | Q07869 | 7/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinimide SCHEMBL28354892 | 1.00 | FFAR3 (0.56) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Succinimide SCHEMBL28398892 | 0.94 | FFAR3 (0.50) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Valeric Acid SCHEMBL14334833 | 0.88 | AKR1B1 (0.52) | CRBNAKR1B1HSD17B10GPR84PPARG | |
| Succinic Acid SCHEMBL27747025 | 0.86 | CRBN (0.58) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Succinic Acid SCHEMBL436244 | 0.86 | CRBN (0.58) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Hexanoate SCHEMBL8761793 | 0.86 | AKR1B1 (0.61) | AKR1B1HSD17B10GPR84PPARGPPARD | |
| Palmitic Acid SCHEMBL23529891 | 0.84 | GPR84 (0.63) | AKR1B1HSD17B10GPR84PPARGPPARD | |
| Stearic Acid SCHEMBL7117718 | 0.84 | GPR84 (0.63) | AKR1B1HSD17B10GPR84PPARGPPARD | |
| Undecanoate SCHEMBL1465216 | 0.84 | GPR84 (0.63) | AKR1B1HSD17B10GPR84PPARGPPARD | |
| Nonanoate SCHEMBL29126342 | 0.84 | GPR84 (0.63) | AKR1B1HSD17B10GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115721730-A | Pegylated vascular endothelial inhibin analogs and uses thereof | 北京普罗吉生物科技发展有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-109963597-B | Pegylated endostatin analogs and uses thereof | 北京普罗吉生物科技发展有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-119816334-A | Sealant for tissue closure | 爱惜康股份有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119780422-A | Alkaline phosphatase antibody marker, preparation method thereof, detection reagent and kit | 深圳市锦瑞生物科技股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| WO-2024017379-A1 | PREPARATION METHOD FOR POLYETHYLENE GLYCOL CONJUGATE OF ACTIVE POLYPEPTIDE OR PROTEIN | 派格生物医药(苏州)股份有限公司 | 2024-01-25 | — | — | WO | disclosed |
| CN-116916969-A | Novel conjugates of immunostimulatory IL-2 analogues and methods of making the same | 韩美药品株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-116724060-A | Compositions and methods for modulating SIRPalpha-mediated signaling | 小利兰·斯坦福大学董事会 | 2023-09-08 | — | — | CN | disclosed |
| CN-116648260-A | Compositions and methods for inhibiting natural killer cell receptors | 小利兰·斯坦福大学董事会 | 2023-08-25 | — | — | CN | disclosed |
| CN-116635050-A | Novel triple agonists active on all of glucagon, GLP-1 and GIP receptors and uses thereof | 韩美药品株式会社 | 2023-08-22 | — | — | CN | disclosed |
| CN-116615254-A | Use of trigonometric agonists active on all of glucagon, GLP-1 and GIP receptors for the treatment of sequelae of respiratory tract infectious diseases | 韩美药品株式会社 | 2023-08-18 | — | — | CN | disclosed |
| CN-116615240-A | Engineered interleukin-10 polypeptides and uses thereof | 小利兰·斯坦福大学董事会 | 2023-08-18 | — | — | CN | disclosed |
| CN-1897976-A | Antagonists of the bradykinin b1 receptor | AMGEN INC (US) | 2007-01-17 | — | — | CN | disclosed |
| CN-1852740-A | Prodrugs of highly branched polymers | NEKTAR THERAPEUTICS AL CORP (US) | 2006-10-25 | — | — | CN | disclosed |
| CN-1777440-A | Method for preparing site-specific protein conjugate | PR PHARMACEUTICALS INC (US) | 2006-05-24 | — | — | CN | disclosed |
| CN-1747748-A | Polymer derivatives having particular atom arrangements | NEKTAR THERAPEUTICS AL CORP (US) | 2006-03-15 | — | — | CN | disclosed |
| CN-1738640-A | Interferon-alpha polypeptides and conjugates | MAXYGEN INC (US) | 2006-02-22 | — | — | CN | disclosed |
| EP-1284743-A2 | PREPARATION OF A PATHOGEN INACTIVATED SOLUTION OF RED BLOOD CELLS HAVING REDUCED IMMUNOGENICITY | Cerus Corporation (US) | 2003-02-26 | — | — | EP | disclosed |
| US-20020042043-A1 | Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity | STASSINOPOULOS ADONIS (US) | 2002-04-11 | — | — | US | disclosed |
| WO-2001091775-A2 | PREPARATION OF A PATHOGEN INACTIVATED SOLUTION OF RED BLOOD CELLS HAVING REDUCED IMMUNOGENICITY | CERUS CORPORATION (US) | 2001-12-06 | — | — | WO | disclosed |
| CN-1251133-A | Bifunctional or multifunctional molecules based on dendroaspin scaffolds | TRIGEN LTD (GB) | 2000-04-19 | — | — | CN | disclosed |